Advertisement
MD vs OPCH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MD is a Buy and OPCH is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MD’s FA Score shows that 0 FA rating(s) are green whileOPCH’s FA Score has 2 green FA rating(s).
- MD’s FA Score: 0 green, 5 red.
- OPCH’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MD’s TA Score shows that 4 TA indicator(s) are bullish while OPCH’s TA Score has 5 bullish TA indicator(s).
- MD’s TA Score: 4 bullish, 5 bearish.
- OPCH’s TA Score: 5 bullish, 3 bearish.
Price Growth
MD (@Medical/Nursing Services) experienced а +6.13% price change this week, while OPCH (@Medical/Nursing Services) price change was +2.28% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.49%. For the same industry, the average monthly price growth was +4.53%, and the average quarterly price growth was +7.40%.
Reported Earning Dates
MD is expected to report earnings on Jul 31, 2025.
OPCH is expected to report earnings on Jul 30, 2025.
Industries' Descriptions
@Medical/Nursing Services (+1.49% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| MD | OPCH | MD / OPCH | |
| Capitalization | 819M | 5.82B | 14% |
| EBITDA | 29.9M | 472M | 6% |
| Gain YTD | 6.936 | 39.009 | 18% |
| P/E Ratio | 7.98 | 22.16 | 36% |
| Revenue | 2B | 4.3B | 46% |
| Total Cash | 178M | 344M | 52% |
| Total Debt | 702M | 1.17B | 60% |
MD | OPCH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 65 | 63 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 49 Fair valued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 33 | |
SMR RATING 1..100 | 93 | 54 | |
PRICE GROWTH RATING 1..100 | 44 | 48 | |
P/E GROWTH RATING 1..100 | 98 | 17 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MD's Valuation (49) in the Medical Or Nursing Services industry is in the same range as OPCH (76) in the null industry. This means that MD’s stock grew similarly to OPCH’s over the last 12 months.
OPCH's Profit vs Risk Rating (33) in the null industry is significantly better than the same rating for MD (100) in the Medical Or Nursing Services industry. This means that OPCH’s stock grew significantly faster than MD’s over the last 12 months.
OPCH's SMR Rating (54) in the null industry is somewhat better than the same rating for MD (93) in the Medical Or Nursing Services industry. This means that OPCH’s stock grew somewhat faster than MD’s over the last 12 months.
MD's Price Growth Rating (44) in the Medical Or Nursing Services industry is in the same range as OPCH (48) in the null industry. This means that MD’s stock grew similarly to OPCH’s over the last 12 months.
OPCH's P/E Growth Rating (17) in the null industry is significantly better than the same rating for MD (98) in the Medical Or Nursing Services industry. This means that OPCH’s stock grew significantly faster than MD’s over the last 12 months.
| MD | OPCH | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 3 days ago 70% | 3 days ago 62% |
| Momentum ODDS (%) | 3 days ago 78% | 3 days ago 78% |
| MACD ODDS (%) | 4 days ago 82% | 3 days ago 59% |
| TrendWeek ODDS (%) | 3 days ago 69% | 3 days ago 69% |
| TrendMonth ODDS (%) | 3 days ago 65% | 3 days ago 68% |
| Advances ODDS (%) | 18 days ago 68% | 3 days ago 67% |
| Declines ODDS (%) | 10 days ago 73% | 10 days ago 64% |
| BollingerBands ODDS (%) | 3 days ago 76% | 3 days ago 71% |
| Aroon ODDS (%) | 3 days ago 69% | 3 days ago 68% |
Advertisement
MD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MD has been loosely correlated with ADUS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MD jumps, then ADUS could also see price increases.